Cannabis News Box

Cannabis Science will expand scope of sponsored research to include neurological conditions

Cannabis Science will expand scope of sponsored research to include neurological conditions

Bethan Rose Jenkins, Cannabis News Writer/Editorial

March 11, 2019

Cannabis Science, Inc. (OTC: CBIS), a U.S.-based company that develops cannabinoid-based medicines,  has revealed its plans to broaden the extent of its sponsored medical cannabis research in Nigeria. Neurological conditions, such as Post-Traumatic Stress Disorder (PTSD), will be added to its re...

cbis research in nigeria